{"id":50762,"date":"2012-08-07T08:16:41","date_gmt":"2012-08-07T08:16:41","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/bristol-myers-squibb-foundation-awards-1-6-million-in-grants-to-help-communities-in-india-address-type-2-diabetes.php"},"modified":"2012-08-07T08:16:41","modified_gmt":"2012-08-07T08:16:41","slug":"bristol-myers-squibb-foundation-awards-1-6-million-in-grants-to-help-communities-in-india-address-type-2-diabetes","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/health-care\/bristol-myers-squibb-foundation-awards-1-6-million-in-grants-to-help-communities-in-india-address-type-2-diabetes.php","title":{"rendered":"Bristol-Myers Squibb Foundation Awards $1.6 Million in Grants to Help Communities in India Address Type 2 Diabetes"},"content":{"rendered":"<p><p>    NEW YORK--(BUSINESS WIRE)--  <\/p>\n<p>        The Bristol-Myers Squibb Foundation today announced $1.6    million in grants to four health care institutions in India    that will help improve diabetes education, prevention and care    and increase health care worker capacity in rural and tribal    areas and among the urban poor.  <\/p>\n<p>    The prevalence of diabetes in India has grown roughly four-fold    since the early 1970s  from about 2 percent of the population    in 1972 to 8.3 percent today  due to factors ranging from    genetic predisposition to lifestyle and dietary changes. The    International Diabetes Foundation (IDF) reports that 61.26    million people in India are diagnosed with type 2 diabetes,    ranking India second only to China in total cases and third    behind the United States (10.9 percent) and China (9.3 percent)    in terms of prevalence. By 2030, India will have 101.2 million    people with type 2 diabetes, IDF projects.  <\/p>\n<p>    Stemming the rising tide of type 2 diabetes in India will    require a concerted and sustained effort at the community level    to ensure adults have access to the education, preventive    measures and care they need to effectively self-manage their    disease, said John Damonti, president, Bristol-Myers Squibb    Foundation. The grants we are making today through our    Together on Diabetes initiative will test    new ideas about how diabetes control efforts can be best    designed and implemented to help adults in a variety of    settings.  <\/p>\n<p>    The Foundation has employed a similar capacity-building    approach with its 10-year-old Delivering    Hope initiative to address hepatitis B    and C in Asia, and its ongoing work to address unmet medical    needs, reduce health disparities and build community health    care capacity was recognized in late July by CMO Asia with an    Asias Best CSR Practices Award in the Concern for    Health category.  <\/p>\n<p>    The following organizations will receive Together on    Diabetes grants:  <\/p>\n<p>    About Together on    Diabetes  <\/p>\n<p>    Together on Diabetes brings together some of    the worlds most respected and influential health care    organizations and academic institutions to develop effective,    comprehensive solutions that integrate public health, health    care services and supportive community supportive services to    improve health outcomes and reduce disease burden.  <\/p>\n<p>    Since its launch in November 2010, Together on    Diabetes has awarded $32.57 million in    grants to 17 organizations working in 23 states and the    District of Columbia in the United States, $1.23 million to two    organizations in China and $1.6 million to four organizations    in India. The total commitment is $115 million through 2014.  <\/p>\n<p>    You can learn more about Together on    Diabetes at     TogetherOnDiabetes.com.  <\/p>\n<\/p>\n<p>Read more from the original source:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/bristol-myers-squibb-foundation-awards-210000223.html;_ylt=A2KJjajYziBQHgcAdOn_wgt.\" title=\"Bristol-Myers Squibb Foundation Awards $1.6 Million in Grants to Help Communities in India Address Type 2 Diabetes\">Bristol-Myers Squibb Foundation Awards $1.6 Million in Grants to Help Communities in India Address Type 2 Diabetes<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> NEW YORK--(BUSINESS WIRE)-- The Bristol-Myers Squibb Foundation today announced $1.6 million in grants to four health care institutions in India that will help improve diabetes education, prevention and care and increase health care worker capacity in rural and tribal areas and among the urban poor. The prevalence of diabetes in India has grown roughly four-fold since the early 1970s from about 2 percent of the population in 1972 to 8.3 percent today due to factors ranging from genetic predisposition to lifestyle and dietary changes. The International Diabetes Foundation (IDF) reports that 61.26 million people in India are diagnosed with type 2 diabetes, ranking India second only to China in total cases and third behind the United States (10.9 percent) and China (9.3 percent) in terms of prevalence <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/health-care\/bristol-myers-squibb-foundation-awards-1-6-million-in-grants-to-help-communities-in-india-address-type-2-diabetes.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[6],"tags":[],"class_list":["post-50762","post","type-post","status-publish","format-standard","hentry","category-health-care"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/50762"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=50762"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/50762\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=50762"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=50762"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=50762"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}